From: A comparison of EQ-5D index scores using the UK, US, and Japan preference weights in a Thai sample with type 2 diabetes
Drug A (new drug)
Drug B (existing drug)
Success
Failure
Probability of treatment results
0.6
0.4
0.5
Survival (year)
10
5
8
4
Utility scores
0.9
0.8
Cost (Baht)
100,000
50,000
80,000
40,000